Ad is loading...
TFX
Price
$187.43
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
90 days until earnings call
WAT
Price
$357.77
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
81 days until earnings call
Ad is loading...

TFX vs WAT

Header iconTFX vs WAT Comparison
Open Charts TFX vs WATBanner chart's image
Teleflex
Price$187.43
Change-$0.00 (-0.00%)
Volume$588.5K
CapitalizationN/A
Waters
Price$357.77
Change-$0.00 (-0.00%)
Volume$688.88K
CapitalizationN/A
TFX vs WAT Comparison Chart
Loading...
TFX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
TFX vs. WAT commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TFX is a StrongBuy and WAT is a Buy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (TFX: $190.64 vs. WAT: $368.50)
Brand notoriety: TFX and WAT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: TFX: 91% vs. WAT: 91%
Market capitalization -- TFX: $10.49B vs. WAT: $20.38B
TFX [@Medical Specialties] is valued at $10.49B. WAT’s [@Medical Specialties] market capitalization is $20.38B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TFX’s FA Score shows that 2 FA rating(s) are green whileWAT’s FA Score has 3 green FA rating(s).

  • TFX’s FA Score: 2 green, 3 red.
  • WAT’s FA Score: 3 green, 2 red.
According to our system of comparison, WAT is a better buy in the long-term than TFX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TFX’s TA Score shows that 4 TA indicator(s) are bullish while WAT’s TA Score has 5 bullish TA indicator(s).

  • TFX’s TA Score: 4 bullish, 4 bearish.
  • WAT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, WAT is a better buy in the short-term than TFX.

Price Growth

TFX (@Medical Specialties) experienced а +0.11% price change this week, while WAT (@Medical Specialties) price change was -2.18% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.47%. For the same industry, the average monthly price growth was -1.10%, and the average quarterly price growth was -2.69%.

Reported Earning Dates

TFX is expected to report earnings on Feb 20, 2025.

WAT is expected to report earnings on Feb 11, 2025.

Industries' Descriptions

@Medical Specialties (+0.47% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WAT($20.4B) has a higher market cap than TFX($10.5B). WAT has higher P/E ratio than TFX: WAT (31.78) vs TFX (29.48). WAT YTD gains are higher at: 11.928 vs. TFX (-23.051). WAT has higher annual earnings (EBITDA): 1B vs. TFX (761M). WAT has more cash in the bank: 396M vs. TFX (223M). TFX has less debt than WAT: TFX (1.93B) vs WAT (2.44B). TFX (2.97B) and WAT (2.96B) have equivalent revenues.
TFXWATTFX / WAT
Capitalization10.5B20.4B51%
EBITDA761M1B76%
Gain YTD-23.05111.928-193%
P/E Ratio29.4831.7893%
Revenue2.97B2.96B101%
Total Cash223M396M56%
Total Debt1.93B2.44B79%
FUNDAMENTALS RATINGS
TFX vs WAT: Fundamental Ratings
TFX
WAT
OUTLOOK RATING
1..100
5361
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
82
Overvalued
PROFIT vs RISK RATING
1..100
10041
SMR RATING
1..100
8220
PRICE GROWTH RATING
1..100
6433
P/E GROWTH RATING
1..100
2329
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TFX's Valuation (19) in the Medical Specialties industry is somewhat better than the same rating for WAT (82). This means that TFX’s stock grew somewhat faster than WAT’s over the last 12 months.

WAT's Profit vs Risk Rating (41) in the Medical Specialties industry is somewhat better than the same rating for TFX (100). This means that WAT’s stock grew somewhat faster than TFX’s over the last 12 months.

WAT's SMR Rating (20) in the Medical Specialties industry is somewhat better than the same rating for TFX (82). This means that WAT’s stock grew somewhat faster than TFX’s over the last 12 months.

WAT's Price Growth Rating (33) in the Medical Specialties industry is in the same range as TFX (64). This means that WAT’s stock grew similarly to TFX’s over the last 12 months.

TFX's P/E Growth Rating (23) in the Medical Specialties industry is in the same range as WAT (29). This means that TFX’s stock grew similarly to WAT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TFXWAT
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 1 day ago
65%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 1 day ago
53%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 1 day ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 1 day ago
66%
Advances
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 1 day ago
66%
Declines
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 3 days ago
61%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 1 day ago
53%
Aroon
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 1 day ago
67%
View a ticker or compare two or three
Ad is loading...
TFX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
USVM89.791.62
+1.83%
VictoryShares US Sm Md Cp Val Momt ETF
USPX52.170.34
+0.65%
Franklin US Equity Index ETF
SCHF19.200.06
+0.31%
Schwab International Equity ETF™
MSFO18.570.02
+0.11%
YieldMax MSFT Option Income Strategy ETF
NDIA30.05-0.21
-0.71%
Global X India Active ETF